Literature DB >> 21840027

Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.

Reed F Johnson1, Srikanth Yellayi, Jennifer A Cann, Anthony Johnson, Alvin L Smith, Jason Paragas, Peter B Jahrling, Joseph E Blaney.   

Abstract

Hemorrhagic smallpox was a rare but severe manifestation of variola virus infection that resulted in nearly 100% mortality. Here we describe intravenous (IV) inoculation of cowpox virus Brighton Red strain in cynomolgus macaques (Macaca fascicularis) which resulted in disease similar in presentation to hemorrhagic smallpox in humans. IV inoculation of macaques resulted in a uniformly lethal disease within 12 days post-inoculation in two independent experiments. Clinical observations and hematological and histopathological findings support hemorrhagic disease. Cowpox virus replicated to high levels in blood (8.0-9.0 log(10) gene copies/mL) and tissues including lymph nodes, thymus, spleen, bone marrow, and lungs. This unique model of hemorrhagic orthopoxvirus infection provides an accessible means to further study orthopoxvirus pathogenesis and to identify virus-specific and nonspecific therapies. Such studies will serve to complement the existing nonhuman primate models of more classical poxviral disease. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840027      PMCID: PMC3164762          DOI: 10.1016/j.virol.2011.07.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.513


  61 in total

1.  Genome-based phylogeny of poxvirus.

Authors:  Ke Xing; Riqiang Deng; Jinwen Wang; Jinghua Feng; Mingsong Huang; Xunzhang Wang
Journal:  Intervirology       Date:  2006-01-11       Impact factor: 1.763

2.  Fatal poxvirus outbreak in a colony of New World monkeys.

Authors:  K Mätz-Rensing; H Ellerbrok; B Ehlers; G Pauli; A Floto; M Alex; C-P Czerny; F-J Kaup
Journal:  Vet Pathol       Date:  2006-03       Impact factor: 2.221

3.  Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation.

Authors:  K Johnson; Y Choi; E DeGroot; I Samuels; A Creasey; L Aarden
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

Review 4.  Animal models of orthopoxvirus infection.

Authors:  J L Chapman; D K Nichols; M J Martinez; J W Raymond
Journal:  Vet Pathol       Date:  2010-08-03       Impact factor: 2.221

5.  Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

Authors:  K J Stittelaar; T Kuiken; R L de Swart; G van Amerongen; H W Vos; H G Niesters; P van Schalkwijk; T van der Kwast; L S Wyatt; B Moss; A D Osterhaus
Journal:  Vaccine       Date:  2001-06-14       Impact factor: 3.641

Review 6.  Chemokines in the pathogenesis of vascular disease.

Authors:  Israel F Charo; Mark B Taubman
Journal:  Circ Res       Date:  2004-10-29       Impact factor: 17.367

7.  Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.

Authors:  Patricia L Earl; Jeffrey L Americo; Linda S Wyatt; Leigh Anne Eller; David C Montefiori; Russ Byrum; Michael Piatak; Jeffrey D Lifson; Rama Rao Amara; Harriet L Robinson; John W Huggins; Bernard Moss
Journal:  Virology       Date:  2007-05-11       Impact factor: 3.616

8.  Haemorrhagic smallpox. 2. Specific bleeding and coagulation studies.

Authors:  P J McKenzie; J H Githens; M E Harwood; J F Roberts; A R Rao; C H Kempe
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

9.  Poxvirus genomes: a phylogenetic analysis.

Authors:  Caroline Gubser; Stéphane Hué; Paul Kellam; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

Review 10.  Cowpox virus infection: an emerging health threat.

Authors:  Rengina M Vorou; Vassilios G Papavassiliou; Ioannis N Pierroutsakos
Journal:  Curr Opin Infect Dis       Date:  2008-04       Impact factor: 4.915

View more
  14 in total

1.  Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease.

Authors:  Reed F Johnson; Lori E Dodd; Srikanth Yellayi; Wenjuan Gu; Jennifer A Cann; Catherine Jett; John G Bernbaum; Dan R Ragland; Marisa St Claire; Russell Byrum; Jason Paragas; Joseph E Blaney; Peter B Jahrling
Journal:  Virology       Date:  2011-10-19       Impact factor: 3.616

2.  Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease.

Authors:  Reed F Johnson; Dima A Hammoud; Donna L Perry; Jeffrey Solomon; Ian N Moore; Matthew G Lackemeyer; Jordan K Bohannon; Philip J Sayre; Mahnaz Minai; Amy B Papaneri; Katie R Hagen; Krisztina B Janosko; Catherine Jett; Kurt Cooper; Joseph E Blaney; Peter B Jahrling
Journal:  J Gen Virol       Date:  2016-05-09       Impact factor: 3.891

Review 3.  The non-human primate model of tuberculosis.

Authors:  D Kaushal; S Mehra; P J Didier; A A Lackner
Journal:  J Med Primatol       Date:  2012-03-20       Impact factor: 0.667

4.  Intrabronchial inoculation of cynomolgus macaques with cowpox virus.

Authors:  Alvin L Smith; Marisa St Claire; Srikanth Yellayi; Laura Bollinger; Peter B Jahrling; Jason Paragas; Joseph E Blaney; Reed F Johnson
Journal:  J Gen Virol       Date:  2011-09-21       Impact factor: 3.891

5.  Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease.

Authors:  Reed F Johnson; Dima A Hammoud; Matthew G Lackemeyer; Srikanth Yellayi; Jeffrey Solomon; Jordan K Bohannon; Krisztina B Janosko; Catherine Jett; Kurt Cooper; Joseph E Blaney; Peter B Jahrling
Journal:  Virology       Date:  2015-03-14       Impact factor: 3.616

6.  Emergence of cowpox: study of the virulence of clinical strains and evaluation of antivirals.

Authors:  Sophie Duraffour; Barbara Mertens; Hermann Meyer; Joost J van den Oord; Tania Mitera; Patrick Matthys; Robert Snoeck; Graciela Andrei
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

7.  Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates.

Authors:  Haifeng Song; Krisztina Janosko; Reed F Johnson; Jing Qin; Nicole Josleyn; Catherine Jett; Russell Byrum; Marisa St Claire; Julie Dyall; Joseph E Blaney; Gerald Jennings; Peter B Jahrling
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

8.  Comparison of host cell gene expression in cowpox, monkeypox or vaccinia virus-infected cells reveals virus-specific regulation of immune response genes.

Authors:  Daniel Bourquain; Piotr Wojtek Dabrowski; Andreas Nitsche
Journal:  Virol J       Date:  2013-02-20       Impact factor: 4.099

9.  Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans.

Authors:  Janet M Leeds; Frederique Fenneteau; Nathalie H Gosselin; Mohamad-Samer Mouksassi; Nastya Kassir; J F Marier; Yali Chen; Doug Grosenbach; Annie E Frimm; Kady M Honeychurch; Jarasvech Chinsangaram; Shanthakumar R Tyavanagimatt; Dennis E Hruby; Robert Jordan
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.938

Review 10.  Challenges and Achievements in Prevention and Treatment of Smallpox.

Authors:  Sharon Melamed; Tomer Israely; Nir Paran
Journal:  Vaccines (Basel)       Date:  2018-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.